news and insights
Explore our latest updates in terms of science, technology, people and our pipeline.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Infrastructure
April 11, 2024
By VRG Therapeutics
VRG Tx Launches Its In Vivo R&D Facility!
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
March 12, 2024
By VRG Therapeutics
Journal of Biological Chemistry
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
AI
February 20, 2024
By VRG Therapeutics
Press release: Experimental verification of our AI-powered drug discovery
White arrow icon up and right direction redirecting to Partner with US page
People
January 8, 2024
By VRG Therapeutics
New member to the team: Dr. Zoltán Urbányi
White arrow icon up and right direction redirecting to Partner with US page
People
January 2, 2024
By VRG Therapeutics
New member to the team: Mariann Kremlitzka, PhD
White arrow icon up and right direction redirecting to Partner with US page
First stage gating meeting of the year
New member to the team: Tamás Csikai
New member to the team: Gábor Oroszlán, PhD
New member to the team: Ambrus Gordos, PharmD
Meet in Italy for Life Sciences - Startup Breeding 2023
New member to the team: Lili Kovanecz-Jármi
New member to the team: Dr. Judit Matúz
International Biotech Days 2023
Bio Europe 2023 - Startup Spotlight
BIO-Europe 2023 Startup Spotlight
Meet in Italy for Life Sciences - Awards
Meet in Italy - Meet the startup: Vrg Therapeutics
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023
Recognition of our student researcher
MBH Bank's Macronome Macroverse conference
Milestone Alert: VRG Tx Launches Its In Vivo R&D Facility!
New member to the team: Ildikó Dósa
Publication - Journal of Biological Chemistry
VRG Therapeutics Advances VRG-145, a Synergistic Oral Combination for Migraine Prophylaxis, to Final Preclinical Stage
CESAwards: We are regional finalists!
New member to the team: Mariann Kremlitzka, PhD
New member to the team: Dr. Zoltán Urbányi
Press release: Experimental verification of our AI-powered drug discovery
Team
May 14, 2024
By VRG Therapeutics
First stage gating meeting of the year
White arrow icon up and right direction redirecting to Partner with US page
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Infrastructure
April 11, 2024
By VRG Therapeutics
VRG Tx Launches Its In Vivo R&D Facility!
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
March 12, 2024
By VRG Therapeutics
Journal of Biological Chemistry
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
AI
February 20, 2024
By VRG Therapeutics
Press release: Experimental verification of our AI-powered drug discovery
White arrow icon up and right direction redirecting to Partner with US page
People
January 8, 2024
By VRG Therapeutics
New member to the team: Dr. Zoltán Urbányi
White arrow icon up and right direction redirecting to Partner with US page
Learn More
Million ways to improve life
Learn More
Million ways to improve life